First e-registration of diabetic patients in BD


FE Online Desk | Published: December 19, 2017 12:00:19 | Updated: December 19, 2017 18:27:59


First e-registration of diabetic patients in BD

 

A nation-wide electronic diabetic patient registration will be introduced in Bangladesh, the first of its kinds, with a view to delivering quality care for patient living with diabetes through analysing epidemiology and treatment outcomes.

The electronic registration will be implemented through the institutions of Diabetic Association of Bangladesh (BADAS) and its affiliated associations across the country with the support of Novo Nordisk.  

 

Diabetic Association of Bangladesh’s (BADAS) President Prof. A.K Azad Khan and Novo Nordisk’s Senior Vice President Frederik Kier recently signed an agreement to develop the registration, said a statement.

 

“In Bangladesh there is no conclusive study or survey which provides an exact number or figure of the diabetic population”, said Prof. Azad Khan. “The new nationwide registry will generate data on patient numbers, blood glucose level before and after meal, three-month average of glucose in blood (HbA1c), renal and cardiac history of patients living with diabetes and other relevance. Quality care will be ensured though analysing these data,” he said.

 

Improving the understanding of diabetes and the need for its prevention is critical, which is why Novo Nordisk works to raise awareness for the diabetes epidemic and its impact in Bangladesh, said Frederick Kier. As a global leader in diabetes care, Novo Nordisk has a responsibility to work for improving understanding of diabetes and the need for its prevention, he said.

 

“The new nationwide registry will provide health outcome data to monitor patient needs and identify health problems that need prompt attention. It will also help to address the rising burden of diabetes to achieve sustainable development goals (SDGs),” he added.

 

The United Nations has recognised diabetes among other non-communicable diseases as a major challenge for achieving SDGs.   

 

Novo Nordisk in partnership with BADAS has taken many initiatives to ensure access to quality care for patients, said Anand Shetty, managing director of Novo Nordisk.  Changing diabetes® barometer, changing diabetes® in children (CDiC) programme and changing diabetes® brand ambassador (One-day cricket captain Mashrafe Bin Mortaza) are to name a few, Shetty said.

 

According to International Diabetes Federation, 6.9 million people are living with diabetes in Bangladesh and it will hit 13.7 million by 2045.

 

-rmc//

Share if you like